{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:01:34Z","timestamp":1789750894081,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bulcan.2017.09.013","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T14:01:17Z","timestamp":1510840877000},"page":"171-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Aspirine et cancer colorectal"],"prefix":"10.1016","volume":"105","author":[{"given":"Adrien","family":"Grancher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Di Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sefrioui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2017.09.013_bib0240","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jso.24578","article-title":"Colorectal cancer-global burden, trends, and geographical variations","volume":"115","author":"Douaiher","year":"2017","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0245","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bpg.2011.10.015","article-title":"Aspirin for the prevention of colorectal cancer","volume":"25","author":"Garcia-Albeniz","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0250","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa067208","article-title":"Aspirin and the risk of colorectal cancer in relation to the expression of COX-2","volume":"356","author":"Chan","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0255","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/1940-6207.CAPR-16-0094","article-title":"Inhibition of the biosynthesis of prostaglandin E2\u00a0by low-dose aspirin: implications for adenocarcinoma metastasis","volume":"9","author":"Boutaud","year":"2016","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0260","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1158\/1940-6207.CAPR-16-0175","article-title":"Aspirin-induced chemoprevention and response kinetics are enhanced by PIK3CA mutations in colorectal cancer cells","volume":"10","author":"Zumwalt","year":"2017","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0265","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-642-30331-9_3","article-title":"Mode of action of aspirin as a chemopreventive agent","volume":"191","author":"Dovizio","year":"2013","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0270","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jacc.2015.05.012","article-title":"The multifaceted clinical readouts of platelet inhibition by low-dose aspirin","volume":"66","author":"Patrono","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0275","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-pathol-011110-130235","article-title":"Molecular genetics of colorectal cancer","volume":"6","author":"Fearon","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0280","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1158\/1078-0432.CCR-14-0877","article-title":"Molecular pathways: aspirin and Wnt signaling \u2013\u00a0a molecularly targeted approach to cancer prevention and treatment","volume":"21","author":"Gala","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0285","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrc.2016.4","article-title":"Aspirin and colorectal cancer: the promise of precision chemoprevention","volume":"16","author":"Drew","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0290","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1158\/0008-5472.CAN-15-0125","article-title":"Definition of prostaglandin E2-EP2\u00a0signals in the colon tumor microenvironment that amplify inflammation and tumor growth","volume":"75","author":"Ma","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.prostaglandins.2014.10.002","article-title":"The role of PGE2\u00a0in intestinal inflammation and tumorigenesis","volume":"116-117","author":"Montrose","year":"2015","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0300","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/mol.115.098616","article-title":"Aspirin targets SIRT1\u00a0and AMPK to induce senescence of colorectal carcinoma cells","volume":"88","author":"Jung","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0305","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2012.02.050","article-title":"Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells","volume":"142","author":"Din","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0310","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrc3004","article-title":"Contribution of platelets to tumour metastasis","volume":"11","author":"Gay","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0315","doi-asserted-by":"crossref","first-page":"32462","DOI":"10.18632\/oncotarget.8655","article-title":"Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells","volume":"7","author":"Guillem-Llobat","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0320","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1001\/jamainternmed.2014.511","article-title":"Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer","volume":"174","author":"Reimers","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0325","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1053\/j.gastro.2016.07.030","article-title":"Regular aspirin use associates with lower risk of colorectal cancers with low numbers of tumor-infiltrating lymphocytes","volume":"151","author":"Cao","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0330","doi-asserted-by":"crossref","first-page":"233re2","DOI":"10.1126\/scitranslmed.3008481","article-title":"Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (15-PGDH, HPGD)","volume":"6","author":"Fink","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0335","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.cgh.2006.07.015","article-title":"Urine PGE-M: a metabolite of prostaglandin E2\u00a0as a potential biomarker of advanced colorectal neoplasia","volume":"4","author":"Johnson","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0340","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2010.11.041","article-title":"Inflammatory markers are associated with risk of colorectal cancer and chemopreventative response to anti-inflammatory drugs","volume":"140","author":"Chan","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0345","doi-asserted-by":"crossref","first-page":"dju010","DOI":"10.1093\/jnci\/dju016","article-title":"A prospective study of macrophage inhibitory cytokine-1 (MIC-1\/GDF15) and risk of colorectal cancer","volume":"106","author":"Mehta","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0350","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/jama.2015.1815","article-title":"Association of aspirin and non-steroidal anti-inflammatory drug use with risk of colorectal cancer according to genetic variants","volume":"313","author":"Nan","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0355","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/gutjnl-2014-308260","article-title":"Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis","volume":"64","author":"Li","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0360","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1200\/JCO.2016.70.7547","article-title":"Aspirin use and colorectal cancer survival according to tumor CD274 (programmed cell death 1\u00a0ligand 1) expression status","volume":"35","author":"Hamada","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0365","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer","volume":"348","author":"Sandler","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0370","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gutjnl-2011-300113","article-title":"Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial","volume":"61","author":"Benamouzig","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0375","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1053\/j.gastro.2015.09.010","article-title":"Aspirin, calcitriol, and calcium do not prevent adenoma recurrence in a randomized controlled trial","volume":"150","author":"Pommergaard","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0380","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/j.gastro.2007.11.007","article-title":"Cigarette smoking and adenomatous polyps: a meta-analysis","volume":"134","author":"Botteri","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0385","doi-asserted-by":"crossref","first-page":"347","DOI":"10.7326\/M15-0039","article-title":"Low-dose aspirin or nonsteroidal anti-inflammatory drug use and colorectal cancer risk: a population-based. Case-control study","volume":"163","author":"Friis","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0390","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","article-title":"Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials","volume":"376","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0395","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-128-9-199805010-00003","article-title":"Aspirin use and colorectal cancer: post-trial follow-up data from the physicians\u2019 health study","volume":"128","author":"St\u00fcrmer","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0400","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-dose aspirin in the primary prevention of cancer: the Women's health study: a randomized controlled trial","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0405","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-159-2-201307160-00002","article-title":"Alternate-day low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial","volume":"159","author":"Cook","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0410","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1053\/j.gastro.2015.11.018","article-title":"Where do we stand with aspirin for the prevention of colorectal cancer? The USPSTF recommendations","volume":"150","author":"Chan","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0415","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cgh.2011.05.020","article-title":"Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis","volume":"9","author":"Lanas","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0420","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Antithrombotic Trialists\u2019 (ATT) Collaboration","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0425","doi-asserted-by":"crossref","first-page":"769","DOI":"10.7326\/0003-4819-135-9-200111060-00007","article-title":"Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer: a cost-effectiveness analysis","volume":"135","author":"Ladabaum","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0430","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.2009.1112","article-title":"Aspirin use and survival after diagnosis of colorectal cancer","volume":"302","author":"Chan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0435","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bjc.2012.101","article-title":"Use of aspirin postdiagnosis improves survival for colon cancer patients","volume":"106","author":"Bastiaannet","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0440","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0445","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1053\/j.gastro.2013.11.005","article-title":"Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort","volume":"146","author":"Cardwell","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0450","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1056\/NEJMoa1207756","article-title":"Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival","volume":"367","author":"Liao","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0455","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1200\/JCO.2013.50.0322","article-title":"Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer","volume":"31","author":"Domingo","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0460","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/0284186X.2014.990158","article-title":"Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation","volume":"54","author":"Kothari","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0465","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/bjc.2015.336","article-title":"Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer","volume":"113","author":"Restivo","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2017.09.013_bib0235","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1093\/jnci\/djt298","article-title":"Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial","volume":"105","author":"Ogino","year":"2013","journal-title":"J Natl Cancer Inst"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455117302643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455117302643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T03:10:48Z","timestamp":1531105848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455117302643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0007455117302643"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2017.09.013","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirine et cancer colorectal","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2017.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}